abstract |
The present invention comprises compounds of the general formula (1) (see formula 1) in which R1 to R4 are as defined in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, as well as its use to prepare a medicine with the previously mentioned properties. |